Kim Kyung-hee, director of the Incheon Sejong Hospital Center, appointed Asia's first director of the International Heart and Lung Transplant Society
Nov 04, 2025
Kim Kyung-hee, Director of the Heart Transplantation Center at Sejong Hospital in Incheon (Cardiology Department) has been elected as the new director of the International Society for Heart and Lung Transplantation (ISHLT) for the first time as an Asian medical team. The term of office is three years. The new board of directors, including Kim Kyung-hee, will be officially launched at the 46th ISHLT Annual Conference (2026) to be held in Toronto, Canada in May next year.
ISHLT is the world's largest academic organization involving more than 5,000 experts from around the world in the fields of heart failure, heart transplantation, lung transplantation, and mechanical circulation assistance (LVAD and ECMO), leading international academic exchanges and research cooperation.
Kim, who serves as the head of the heart transplant center and a doctor in charge of heart failure and transplantation at Incheon Sejong Hospital, plays a leading role in various clinical and academic fields, including heart transplant patient management, left ventricular assistive device (LVAD) treatment, and early diagnosis of heart failure using artificial intelligence (AI).
In addition, it is attracting attention from domestic and international academia with extensive research and achievements in hereditary cardiomyopathy, pulmonary hypertension, and the association between metabolic diseases and cardiovascular system.
Kim's election as Asia's first ISHLT director is considered a meaningful achievement that shows that Korea's ability to treat heart transplants and heart failure is also recognized on the global medical stage.
Kim Kyung-hee, Director of the Heart Transplantation Center at Sejong Hospital in Incheon, said "As a member of the ISHLT, we will share our experiences and achievements in the Asia-Pacific region internationally, while expanding our cooperative network for better patient treatment in the future.", he expressed his feelings.
Oh Byung-hee, Director of Sejong Hospital in Incheon, said, `We expect that the joining of the ISHLT board of directors by Kim will further strengthen Korea's influence in the international medical arena in the future.'
ISHLT is the world's largest academic organization involving more than 5,000 experts from around the world in the fields of heart failure, heart transplantation, lung transplantation, and mechanical circulation assistance (LVAD and ECMO), leading international academic exchanges and research cooperation.
Kim, who serves as the head of the heart transplant center and a doctor in charge of heart failure and transplantation at Incheon Sejong Hospital, plays a leading role in various clinical and academic fields, including heart transplant patient management, left ventricular assistive device (LVAD) treatment, and early diagnosis of heart failure using artificial intelligence (AI).
In addition, it is attracting attention from domestic and international academia with extensive research and achievements in hereditary cardiomyopathy, pulmonary hypertension, and the association between metabolic diseases and cardiovascular system.
Kim's election as Asia's first ISHLT director is considered a meaningful achievement that shows that Korea's ability to treat heart transplants and heart failure is also recognized on the global medical stage.
Kim Kyung-hee, Director of the Heart Transplantation Center at Sejong Hospital in Incheon, said "As a member of the ISHLT, we will share our experiences and achievements in the Asia-Pacific region internationally, while expanding our cooperative network for better patient treatment in the future.", he expressed his feelings.
Oh Byung-hee, Director of Sejong Hospital in Incheon, said, `We expect that the joining of the ISHLT board of directors by Kim will further strengthen Korea's influence in the international medical arena in the future.'
|
This article was translated by Naver AI translator.
